肝硬化急性失代偿患者的细胞死亡标志物
研究基于CANONIC队列337例患者(急性失代偿258例、慢加急性肝衰竭79例)及健康志愿者、稳定期肝硬化患者和16例急性失代偿患者肝组织学队列,检测血浆cK18、K18及cK18:K18比值。结果显示细胞死亡标志物随急性失代偿和慢加急性肝衰竭严重程度增加而升高,cK18:K18比值下降,非凋亡性细胞死亡占主导,纳入cK18和K18可改善CLIF-C AD评分对进展至慢加急性肝衰竭的预测。
要点
- cK18和K18浓度随急性失代偿和慢加急性肝衰竭严重程度增加而升高,cK18:K18比值下降(P均<0.001)。
- 酒精病因、既往无失代偿及酒精滥用与细胞死亡标志物升高相关,而基础感染不相关。
- 纳入cK18和K18可改善CLIF-C AD评分对急性失代偿进展至慢加急性肝衰竭的预测(P<0.05)。
核心结论
- 细胞死亡(可能为肝源性)是急性失代偿和慢加急性肝衰竭的重要特征,其幅度与临床严重程度相关。
- 随着急性失代偿和慢加急性肝衰竭严重程度增加,非凋亡形式的细胞死亡占主导。
- 数据提示慢加急性肝衰竭是一异质性实体,细胞死亡在其病理生理中的重要性取决于易感因素、诱发疾病、损伤反应和器官衰竭类型。
研究设计与样本
- 研究患者来自CANONIC研究(N=337;急性失代偿258例,慢加急性肝衰竭79例),另设健康志愿者、稳定期肝硬化患者及16例急性失代偿患者用于组织学研究。
- 采用酶联免疫吸附试验检测血浆cK18、K18及cK18:K18比值(凋亡指数)。
- 采用末端脱氧核苷酸转移酶dUTP缺口末端标记染色评估肝细胞死亡。
主要发现
- cK18和K18浓度随急性失代偿和慢加急性肝衰竭严重程度增加而升高,cK18:K18比值下降(P均<0.001)。
- 酒精病因、既往无失代偿及酒精滥用与细胞死亡标志物升高相关,而基础感染不相关。
- 细胞死亡标志物与全身炎症标志物、肝衰竭标志物、丙氨酸氨基转移酶和胆红素密切相关,但与肝外器官损伤标志物不相关。
- 末端脱氧核苷酸转移酶dUTP缺口末端标记染色证实慢加急性肝衰竭患者较急性失代偿患者肝细胞死亡更多。
- 纳入cK18和K18可改善CLIF-C AD评分对急性失代偿进展至慢加急性肝衰竭的预测(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The aims of this study were to determine the role of cell death in patients with cirrhosis and acute decompensation (AD) and acute on chronic liver failure (ACLF) using plasma-based biomarkers. The patients studied were part of the CANONIC (CLIF Acute-on-Chronic Liver Failure in Cirrhosis) study (N = 337; AD, 258; ACLF, 79); additional cohorts included healthy volunteers, stable patients with cirrhosis, and a group of 16 AD patients for histological studies. Caspase-cleaved keratin 18 (cK18) and keratin 18 (K18), which reflect apoptotic and total cell death, respectively, and cK18:K18 ratio (apoptotic index) were measured in plasma by enzyme-linked immunosorbent assay. The concentrations of cK18 and K18 increased and the cK18:K18 ratio decreased with increasing severity of AD and ACLF (P < 0.001, respectively). Alcohol etiology, no previous decompensation, and alcohol abuse were associated with increased cell death markers whereas underlying infection was not. Close correlation was observed between the cell death markers and, markers of systemic inflammation, hepatic failure, alanine aminotransferase, and bilirubin, but not with markers of extrahepatic organ injury. Terminal deoxynucleotidyl transferase dUTP nick-end labeling staining confirmed evidence of greater hepatic cell death in patients with ACLF as opposed to AD. Inclusion of cK18 and K18 improved the performance of the CLIF-C AD score in prediction of progression from AD to ACLF (P < 0.05). CONCLUSION: Cell death, likely hepatic, is an important feature of AD and ACLF and its magnitude correlates with clinical severity. Nonapoptotic forms of cell death predominate with increasing severity of AD and ACLF. The data suggests that ACLF is a heterogeneous entity and shows that the importance of cell death in its pathophysiology is dependent on predisposing factors, precipitating illness, response to injury, and type of organ failure. (Hepatology 2018;67:989-1002).
引用
- Macdonald S, Andreola F, Bachtiger P, et al. Cell death markers in patients with cirrhosis and acute decompensation. Hepatology. 2018. PMID: 29023872. doi:10.1002/hep.29581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。